HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 564 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,802 | +12.5% | 41,511 | 0.0% | 0.06% | +19.6% |
| Q2 2023 | $4,269 | -40.0% | 41,511 | -36.3% | 0.05% | -39.3% |
| Q1 2023 | $7,111 | -3.1% | 65,156 | +1.0% | 0.08% | -7.7% |
| Q4 2022 | $7,340 | -99.8% | 64,506 | -6.9% | 0.09% | +56.9% |
| Q3 2022 | $4,286,000 | -33.9% | 69,266 | -14.7% | 0.06% | -26.6% |
| Q2 2022 | $6,480,000 | -27.0% | 81,246 | -3.7% | 0.08% | -15.1% |
| Q1 2022 | $8,880,000 | -11.7% | 84,411 | -9.5% | 0.09% | -4.1% |
| Q4 2021 | $10,055,000 | -13.6% | 93,316 | -12.2% | 0.10% | -17.1% |
| Q3 2021 | $11,644,000 | +9.0% | 106,301 | -6.8% | 0.12% | +8.3% |
| Q2 2021 | $10,680,000 | +3356.3% | 114,064 | +2599.7% | 0.11% | +2600.0% |
| Q4 2020 | $309,000 | +4.4% | 4,225 | +10.8% | 0.00% | 0.0% |
| Q3 2020 | $296,000 | -9.5% | 3,812 | -35.4% | 0.00% | 0.0% |
| Q2 2020 | $327,000 | +87.9% | 5,898 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $174,000 | – | 5,898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |